Optimizing sample size in relative bioavailability trials using a Bayesian decision-theoretic framework (Q4964398)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Optimizing sample size in relative bioavailability trials using a Bayesian decision-theoretic framework |
scientific article; zbMATH DE number 7316853
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Optimizing sample size in relative bioavailability trials using a Bayesian decision-theoretic framework |
scientific article; zbMATH DE number 7316853 |
Statements
Optimizing sample size in relative bioavailability trials using a Bayesian decision-theoretic framework (English)
0 references
2 March 2021
0 references
bioavailability
0 references
bioequivalence
0 references
decision theory
0 references
pharmacokinetic (PK) parameter
0 references
0.7436533570289612
0 references
0.729450523853302
0 references
0.7149136066436768
0 references
0.7145341634750366
0 references
0.7083234786987305
0 references
